Abstract
Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine-preventable may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and schedule vaccinations for them to reduce the infection-related burden of patients with IBD. All patients with IBD should be assessed in terms of immunity to vaccine-preventable diseases at the time of IBD diagnosis, and be vaccinated appropriately. Vaccination is becoming more important because of the unprecedented coronavirus disease 2019 (COVID-19) global health crisis. This review focuses on recent updates to vaccination strategies for Korean patients with IBD.
| Original language | English |
|---|---|
| Pages (from-to) | 920-930 |
| Number of pages | 11 |
| Journal | Korean Journal of Internal Medicine |
| Volume | 37 |
| Issue number | 5 |
| DOIs | |
| State | Published - Sep 2022 |
Keywords
- COVID-1
- Inflammatory bowel diseases
- Vaccination